Gladstone Investment Corporation (GAIN) is a NASDAQ-listed business development company that provides debt and equity capital to lower-middle-market companies. A small group of active sell-side targets — generally three to four, depending on the data provider — is tightly clustered. The most recent verified moves include Clear Street raising its target to $17 (Buy) in October 2026, and Oppenheimer maintaining an Outperform rating with a $17 target in May 2026. B. Riley Securities also upgraded the stock to Buy in May 2026, with reported targets in the $16.50-to-$17 area depending on the source.
The rounded arithmetic mean of these verified targets is $17, with an approximate low-to-high range of $16.50 to $17. That narrow range reflects how closely analysts agree on the name's near-term value. The consensus leans "Buy," though at least one data provider still counts a Hold in the mix. Because GAIN is a BDC, analysts tend to anchor targets to NAV growth and dividend coverage rather than the EPS multiples used for ordinary operating companies. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
At a recent price of about $15.09, the move to $17 implies roughly 12.7% upside — a modest step in percentage terms. The path is anchored by the company's book value. NAV per share rose to $16.78 as of March 31, 2026, up from $14.95 three months earlier, driven largely by unrealized appreciation in the portfolio. That means the shares trade at a discount to NAV, which some investors view as an entry point if portfolio marks hold up.
The stock has been volatile, with a 52-week range spanning roughly $13.11 to $17.14. Reaching $17 would effectively revisit the upper end of that range, so the target is not a far-off aspiration but a return to levels the stock has already approached. The question is whether credit fundamentals and investor sentiment can carry it back there and sustain it.
The 52-week high near $17.14 stands as the clearest resistance zone — almost exactly where the $17 target sits. The recent low near $13.11 marks the lower end of the trading range, with an intermediate support area around $14.50 to $15.00, where the stock has repeatedly found buyers in recent months. A sustained push above $17 would require breaking through that prior-high zone, while a slide back toward $14.50 would keep the stock anchored in the lower half of its range.
Analyst price targets generally reflect a research horizon of about 12 months, though the exact window is not always disclosed and varies by firm. Investors should monitor quarterly results for changes in net investment income, the non-accrual rate, and NAV per share; any shifts in the monthly dividend or supplemental distributions; and broader BDC-sector conditions, including middle-market loan spreads and the interest-rate outlook from the FOMC (Federal Open Market Committee). Analyst revisions and changes to credit-quality commentary will matter as much as the headline target. From what I see, using Tickeron’s AI Trend Prediction Engine can help flag potential shifts in these areas ahead of time.
Can Gladstone Investment reach $17? The target is modest — roughly 12.7% above the recent price — and is directly anchored to a NAV that already sits near $16.78 per share. The analyst range is unusually tight, suggesting broad agreement on value. The supports are tangible: a rising book value, an attractive monthly yield, and recent upgrades. The obstacles are equally real: elevated non-accruals, a net investment loss, and sector-wide credit concerns. Whether the stock reclaims $17 will likely depend on whether credit quality stabilizes and NAV keeps climbing, rather than on any single catalyst. No price target is a guarantee, and the outcome will hinge on fundamentals and market conditions that remain in flux.
In my own research process, I’ve found AI Daily Buy/Sell Signals helpful for tracking names like this. The tool uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. Traders can use these signals to discover new opportunities, monitor existing positions, and spot shifting trends more efficiently than scanning charts manually. For those following GAIN or building a broader watchlist, the tool offers a streamlined way to stay on top of daily market developments.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The Moving Average Convergence Divergence (MACD) for GAIN turned positive on October 28, 2026. Looking at past instances where GAIN's MACD turned positive, the stock continued to rise in 27 of 52 cases over the following month. The odds of a continued upward trend are 52%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where GAIN's RSI Indicator exited the oversold zone, 11 of 22 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 50%.
The Momentum Indicator moved above the 0 level on October 28, 2026. You may want to consider a long position or call options on GAIN as a result. In 51 of 100 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 51%.
Following a +2.28% 3-day Advance, the price is estimated to grow further. Considering data from situations where GAIN advanced for three days, in 141 of 313 cases, the price rose further within the following month. The odds of a continued upward trend are 45%.
GAIN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 28 of 62 cases where GAIN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 45%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GAIN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 47%.
The Aroon Indicator for GAIN entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Profit vs. Risk Rating rating for this company is 11 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock better than average.
The Tickeron SMR rating for this company is 29 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating fairly steady price growth. GAIN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 84 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.915) is normal, around the industry mean (2.412). P/E Ratio (3.488) is within average values for comparable stocks, (-2.386). GAIN's Projected Growth (PEG Ratio) (5.409) is very high in comparison to the industry average of (1.319). Dividend Yield (0.022) settles around the average of (0.270) among similar stocks. P/S Ratio (3.959) is also within normal values, averaging (15.694).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a private equity fund
Industry InvestmentManagers